Literature DB >> 9473014

Management of elevated intracranial pressure in patients with Cryptococcal meningitis.

R D Fessler1, J Sobel, L Guyot, L Crane, J Vazquez, M J Szuba, F G Diaz.   

Abstract

BACKGROUND: The most important predictor of early mortality in patients with HIV-associated cryptococcal meningitis is mental status at presentation; patients who present with altered mental status have up to 25% mortality. Historically, cerebrospinal fluid (CSF) diversion in HIV-negative patients with cryptococcal meningitis and signs of elevated intracranial pressure (ICP) has improved survival. In an effort to affect survival and morbidity rates in patients with HIV-associated cryptococcal meningitis, we have initiated aggressive management of elevated ICP in patients with focal neurologic deficits, mental obtundation, or both.
METHODS: We identified 10 patients with HIV-associated cryptococcal meningitis who presented with symptoms consistent with elevated ICP, including headache, mental obtundation, papilledema, and cranial nerve palsies. Elevated opening pressure was defined as > 20 cm CSF during lumbar puncture. In patients with elevated opening pressures who had focal neurologic deficits or mental status changes refractory to serial lumbar puncture, management consisted of immediate placement of lumbar drains for continuous drainage of CSF to maintain normal ICP (10 cm CSF). Patients with persistent elevations of spinal neuraxis pressure following lumbar drainage underwent placement of lumbar peritoneal shunts.
RESULTS: All patients returned to their baseline level of consciousness following normalization of ICP. Two patients were weaned from lumbar drainage. Eight patients eventually required placement of lumbar peritoneal shunts for persistently elevated ICP despite successful antifungal therapy. Follow-up ranged from 1 to 15 months. One shunt infection occurred, one lumbar peritoneal shunt was converted to a ventriculoperitoneal shunt, and one shunt was removed.
CONCLUSIONS: Elevated ICP in patients with HIV-associated cryptococcal meningitis is a significant source of morbidity and mortality. The use of lumbar drainage and selective placement of lumbar peritoneal shunts in the management of elevated ICP in patients with HIV-associated cryptococcal meningitis can ameliorate the sequelae of elevated ICP.

Entities:  

Mesh:

Year:  1998        PMID: 9473014     DOI: 10.1097/00042560-199802010-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  20 in total

1.  Chronic Meningitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

2.  Cryptococcal Meningitis: Diagnosis and Management Update.

Authors:  Mahsa Abassi; David R Boulware; Joshua Rhein
Journal:  Curr Trop Med Rep       Date:  2015-06-01

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 4.  An update on Cryptococcus among HIV-infected patients.

Authors:  T Warkentien; N F Crum-Cianflone
Journal:  Int J STD AIDS       Date:  2010-10       Impact factor: 1.359

5.  Novel Treatment of Cryptococcal Meningitis via Neurapheresis Therapy.

Authors:  Gordon J Smilnak; Lefko T Charalambous; Drew Cutshaw; Alykhan M Premji; Charles D Giamberardino; Christi G Ballard; Andrew P Bartuska; Tiffany U Ejikeme; Huaxin Sheng; Laura Zitella Verbick; Blake A Hedstrom; Promila C Pagadala; Aaron R McCabe; John R Perfect; Shivanand P Lad
Journal:  J Infect Dis       Date:  2018-08-24       Impact factor: 5.226

6.  Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications.

Authors:  D A Stevens; D W Denning; S Shatsky; R W Armstrong; J D Adler; B H Lewis
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 7.  New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.

Authors:  Arthur Jackson; Charles van der Horst
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

8.  Management of Increased Intracranial Pressure in Cryptococcal Meningitis.

Authors:  Kimberly J. Gambarin; Richard J. Hamill
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

9.  Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure.

Authors:  A Georgi; M Schneemann; K Tintelnot; R C Calligaris-Maibach; S Meyer; R Weber; P P Bosshard
Journal:  Infection       Date:  2009-04-23       Impact factor: 3.553

Review 10.  Central nervous system infections in individuals with HIV-1 infection.

Authors:  Arunima Mamidi; Joseph A DeSimone; Roger J Pomerantz
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.